Verity Asset Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,492
Closed -$331K 206
2025
Q1
$331K Buy
+5,492
New +$341K 0.13% 141
2023
Q3
Sell
-4,437
Closed -$251K 178
2023
Q2
$251K Buy
+4,437
New +$244K 0.19% 143
2022
Q4
Sell
-4,271
Closed -$202K 190
2022
Q3
$202K Buy
+4,271
New +$222K 0.21% 160
2021
Q3
Sell
-4,122
Closed -$248K 211
2021
Q2
$248K Buy
+4,122
New +$238K 0.14% 185
2018
Q2
Sell
-54,054
Closed -$1.67M 124
2018
Q1
$1.67M Sell
54,054
-2,070
-4% -$63.8K 1.52% 17
2017
Q4
$1.79M Sell
56,124
-1,944
-3% -$56.1K 1.35% 18
2017
Q3
$1.67M Sell
58,068
-14,886
-20% -$412K 1.27% 18
2017
Q2
$2.03M Buy
72,954
+780
+1% +$20.7K 1.52% 16
2017
Q1
$1.82M Buy
+72,174
New +$1.75M 1.51% 12

Other funds holding IHI

Verity Asset Management's IHI Position: Q2 2025 in Review

Verity Asset Management sold out of iShares US Medical Devices ETF (IHI) in Q2 2025, closing a stake of 5,492 shares — an estimated $331K sold.

Verity Asset Management first reported a position in IHI in Q1 2017 and held it in 9 quarters. The position peaked at $2.03M in Q2 2017. 547 funds tracked by Wall St. Rank hold IHI as of Q2 2025.

  • Verity Asset Management reported no remaining iShares US Medical Devices ETF position as of Q2 2025 after selling out during the quarter.
  • Verity Asset Management sold 5,492 iShares US Medical Devices ETF shares in Q2 2025, an estimated $331K.
  • Verity Asset Management first reported a position in iShares US Medical Devices ETF in Q1 2017 and held it in 9 quarters.
  • Verity Asset Management's iShares US Medical Devices ETF position peaked at $2.03M in Q2 2017.
  • 547 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2025.

Based on Verity Asset Management's 13F filing for Q2 2025, filed 5 Aug 2025.